Inventor · disambiguated record
Maire Eloranta
Also filed as: ELORANTA MAIRE · ELORANTA MAIRE M
11 granted patents·37 citations·filing 1984–2015
85Inventor score
Top patents by PatentIndex Score
11 records- 0177US7504530B2Methods for the preparation of fispemifene from ospemifeneHORMOS MEDICAL LTD·Filed 2008·Granted Mar 17, 2009·4 cites·14 claims
- 0275US7812197B2Method for the preparation of therapeutically valuable triphenylbutene derivativesHORMOS MEDICAL LTD·Filed 2008·Granted Oct 12, 2010·2 cites·12 claims
- 0359US5498623A4(5) substituted imidazoles and their preparation and useORION YHTYMAE OY·Filed 1992·Granted Mar 12, 1996·15 cites·25 claims
- 0456US6313311B1Imidazole derivatives having affinity for alpha2 receptorsORION CORP·Filed 1996·Granted Nov 6, 2001·14 cites·24 claims
- 0551US10626140B2Prodrugs of 17β-HSD1-inhibitorsFORENDO PHARMA LTD·Filed 2015·Granted Apr 21, 2020·0 cites·12 claims
- 0644US10377791B2Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1FORENDO PHARMA LTD·Filed 2014·Granted Aug 13, 2019·0 cites·16 claims
- 0743US9663549B2Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenaseFORENDO PHARMA LTD·Filed 2014·Granted May 30, 2017·0 cites·24 claims
- 0843US6479530B2Imidazole derivatives having affinity for α2 receptorsORION CORP·Filed 2001·Granted Nov 12, 2002·0 cites·18 claims
- 0939US8293947B2Method for the preparation of therapeutically valuable triphenylbutene derivativesSODERVALL MARJA·Filed 2010·Granted Oct 23, 2012·0 cites·21 claims
- 1033US10413557B2Prodrugs of 17.BETA.-HSD1-inhibitorsFORENDO PHARMA LTD·Filed 2015·Granted Sep 17, 2019·0 cites·12 claims
- 1133US4960939AProcess for the preparation of 3,4-di-methoxy-N-methyl-phenethylamineFARMOS OY·Filed 1984·Granted Oct 2, 1990·2 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Maire Eloranta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →